Research prototype, not medical advice.

Blagosklonny proposes that aging is driven mainly by growth programs (notably mTOR) that keep running after development, causing cellular hyperfunction; the theory predicted that rapamycin would slow aging.

Confidence
Speculative
Level of evidence
Observations in humans
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Hyperfunction / quasi-program theorymTOR (mTORC1)Rapamycin (and analogues: everolimus)

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
Blagosklonny · Cell Cycle 2006
— Verified

Related claims